GearR.W., GordonN.C., HellerP.H., PaulS.M., MiaskowskiC., LevineJ.D.Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett., 1996; 205(3):207–209.
2.
GearR.W., MiaskowskiC., GordonN.C., PaulS.M., HellerP.H., LevineJ.D.Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med., 1996; 2(11):1248–1250.
3.
GearR.W., MiaskowskiC., GordonN.C., PaulS.M., HellerP.H., LevineJ.D.The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain, 1999; 83(2):339–345.
4.
RademakerM.Do women have more adverse drug reactions?. Am J Clin Dermatol., 2001; 2(6):349–351.
5.
MeibohmB., BeierleI., DerendorfH.How important are gender differences in pharmacokinetics?. Clin Pharmakokinet., 2002; 41(5):329–342.
6.
HolmesM.D., WillettW.C.Does diet affect breast cancer risk?. Breast Cancer Res., 2004; 6(4):170–178.
7.
HallG.B., WitelsonS.F., SzechtmanH., NahmiasC.Sex differences in functional activation patterns revealed by increased emotion processing demands. Neuroreport, 2004; 15(2):219–223.
8.
GurR.E., KohlerC., TuretskyB.I., SiegelS.J., KanesS.J., BilkerW.B., et al.A sexually dimorphic ratio of obrbitofrontal to amygdala volume is altered in schizophrenia. Biol Psychiatry., 2004; 55(5):512–517.
UsallJ., ArayaS., OchoaS., BusquetsE., GostA., MarquezM.Gender differences in a sample of schizophrenic outpatients. Compr Psychiatry., 2001; 42(4):301–305.
11.
BurtV.K., SteinK.Epidemiology of depression through the female life cycle. J Clin Psychiatry., 2002; 63(Suppl 7):9–15.
12.
Muck-SelerD., PivacN., JakovljevicM.Sex differences, season of birth, and platelet 5-HT levels in schizophrenic patients. J Neural Transm., 1999; 106(3-4):336–347.
13.
Fast Facts on Osteoporosis. National Institutes of Health, Osteoporosis and Related Bone Diseases National Resource Center; February2004. At http://www.osteo.org/newfile.asp?doc=fast&doctitle=Fast+Facts+on+Osteporosis+doctype=HTML+Fact+Sheet. Accessed 2July2004.